Goldberg Andrew D.
Reporting Owner SEC Filing List

CIK: 0001827722
FormFilerSubject CompanyFiling AgentDateActions
3Initial statement of beneficial ownershi...Goldberg Andrew D.Donnelley Financial Solutions /fa/04/21/2026
3Initial statement of beneficial ownershi...Achieve Life Sciences, Inc.Donnelley Financial Solutions /fa/04/21/2026
4Statement of changes in beneficial owner...Goldberg Andrew D.Donnelley Financial Solutions /fa/04/21/2026
4Statement of changes in beneficial owner...Achieve Life Sciences, Inc.Donnelley Financial Solutions /fa/04/21/2026
4Statement of changes in beneficial owner...Tarsus Pharmaceuticals, Inc.Tarsus Pharmaceuticals, Inc. /fa06/16/2025
4Statement of changes in beneficial owner...Goldberg Andrew D.Tarsus Pharmaceuticals, Inc. /fa06/16/2025
4Statement of changes in beneficial owner...Goldberg Andrew D.Tarsus Pharmaceuticals, Inc. /fa03/11/2025
4Statement of changes in beneficial owner...Tarsus Pharmaceuticals, Inc.Tarsus Pharmaceuticals, Inc. /fa03/11/2025
4Statement of changes in beneficial owner...Goldberg Andrew D.Tarsus Pharmaceuticals, Inc. /fa06/25/2024
4Statement of changes in beneficial owner...Tarsus Pharmaceuticals, Inc.06/25/2024
Load More

Goldberg Andrew D. 's Ownership Transactions

IssuerFiling
Date
Transaction
Date
Transaction
Type
SharesPriceTotal AmtShares Owned